Literature DB >> 21841108

Anti-inflammatory therapy for obstructive sleep apnea in children.

Bat-Chen Friedman1, Ran D Goldman.   

Abstract

QUESTION: A 4-year-old child was diagnosed by polysomnography as experiencing mild obstructive sleep apnea (OSA). Despite the child being inattentive and distracted during the day at school, his parents prefer to avoid surgical treatment (adenotonsillectomy). Are there any non-surgical treatments for mild OSA in young children? ANSWER: Obstructive sleep apnea in children is caused mainly by adenotonsillar hypertrophy and can lead to considerable morbidities, including neurocognitive and behavioural disturbances. Surgical removal of the tonsils and adenoids is the treatment of choice. In recent years, however, a new understanding of the inflammatory components of OSA has led to the assumption that anti-inflammatory treatment can reduce adenotonsillar size and improve OSA symptoms. Evidence from a few studies suggests that intranasal steroids and oral leukotriene receptor antagonists have beneficial effects, but data from randomized controlled trials are still lacking.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21841108      PMCID: PMC3155440     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  17 in total

1.  Intranasal steroids and oral leukotriene modifier therapy in residual sleep-disordered breathing after tonsillectomy and adenoidectomy in children.

Authors:  Leila Kheirandish; Aviv D Goldbart; David Gozal
Journal:  Pediatrics       Date:  2006-01       Impact factor: 7.124

2.  Complications of paediatric tonsillectomy post-discharge.

Authors:  W C Lee; J F Sharp
Journal:  J Laryngol Otol       Date:  1996-02       Impact factor: 1.469

3.  Efficacy of fluticasone nasal spray for pediatric obstructive sleep apnea.

Authors:  R T Brouillette; J J Manoukian; F M Ducharme; K Oudjhane; L G Earle; S Ladan; A Morielli
Journal:  J Pediatr       Date:  2001-06       Impact factor: 4.406

4.  Clinical practice guideline: diagnosis and management of childhood obstructive sleep apnea syndrome.

Authors: 
Journal:  Pediatrics       Date:  2002-04       Impact factor: 7.124

5.  Leukotriene modifier therapy for mild sleep-disordered breathing in children.

Authors:  Aviv D Goldbart; Julie L Goldman; Maria C Veling; David Gozal
Journal:  Am J Respir Crit Care Med       Date:  2005-05-05       Impact factor: 21.405

6.  Do systemic corticosteroids effectively treat obstructive sleep apnea secondary to adenotonsillar hypertrophy?

Authors:  S A Al-Ghamdi; J J Manoukian; A Morielli; K Oudjhane; F M Ducharme; R T Brouillette
Journal:  Laryngoscope       Date:  1997-10       Impact factor: 3.325

7.  Differential expression of cysteinyl leukotriene receptors 1 and 2 in tonsils of children with obstructive sleep apnea syndrome or recurrent infection.

Authors:  Aviv D Goldbart; Julie L Goldman; Richard C Li; Kenneth R Brittian; Riva Tauman; David Gozal
Journal:  Chest       Date:  2004-07       Impact factor: 9.410

8.  Neurobehavioral implications of habitual snoring in children.

Authors:  Louise M O'Brien; Carolyn B Mervis; Cheryl R Holbrook; Jennifer L Bruner; Carrie J Klaus; Jennifer Rutherford; Troy J Raffield; David Gozal
Journal:  Pediatrics       Date:  2004-07       Impact factor: 7.124

9.  Increased cellular proliferation and inflammatory cytokines in tonsils derived from children with obstructive sleep apnea.

Authors:  Jinkwan Kim; Rakesh Bhattacharjee; Ehab Dayyat; Ayelet B Snow; Leila Kheirandish-Gozal; Julie L Goldman; Richard C Li; Laura D Serpero; Heather B Clair; David Gozal
Journal:  Pediatr Res       Date:  2009-10       Impact factor: 3.756

10.  Nasal corticosteroids for children with snoring.

Authors:  Emmanouel I Alexopoulos; Athanasios G Kaditis; Efthimia Kalampouka; Eleni Kostadima; Nikiforos V Angelopoulos; Vasiliki Mikraki; Nikolaos Skenteris; Konstantinos Gourgoulianis
Journal:  Pediatr Pulmonol       Date:  2004-08
View more
  7 in total

1.  Continuous positive airway pressure for obstructive sleep apnea in children.

Authors:  Jessie J Wang; Toshihiro Imamura; James Lee; Marie Wright; Ran D Goldman
Journal:  Can Fam Physician       Date:  2021-01       Impact factor: 3.275

2.  Role of the L-PGDS-PGD2-DP1 receptor axis in sleep regulation and neurologic outcomes.

Authors:  Abdullah Shafique Ahmad; Haneen Ottallah; Carolina B Maciel; Michael Strickland; Sylvain Doré
Journal:  Sleep       Date:  2019-06-11       Impact factor: 5.849

Review 3.  Non-surgical treatment of obstructive sleep apnea syndrome.

Authors:  Xu Tingting; You Danming; Chen Xin
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-11-24       Impact factor: 2.503

4.  Effectiveness of azelastine nasal spray in the treatment of adenoidal hyper-trophy in children.

Authors:  G Berkiten; T L Kumral; O Çakır; G Yıldırım; Z Salturk; Y Uyar; Y Atar
Journal:  Hippokratia       Date:  2014 Oct-Dec       Impact factor: 0.471

Review 5.  Tonsillectomy or adenotonsillectomy versus non-surgical management for obstructive sleep-disordered breathing in children.

Authors:  Roderick P Venekamp; Benjamin J Hearne; Deepak Chandrasekharan; Helen Blackshaw; Jerome Lim; Anne G M Schilder
Journal:  Cochrane Database Syst Rev       Date:  2015-10-14

6.  Continuous positive airway pressure therapy suppresses inflammatory cytokines and improves glucocorticoid responsiveness in patients with obstructive sleep apnea and asthma: A case-control study.

Authors:  Bassam Mahboub; Zelal Kharaba; Rakhee K Ramakrishnan; Narjes Saheb Sharif Askari; Laila Ibraheem Salameh; Hassan Saber Alhariri; Mayank G Vats; Wafa Taleb Erabia; Esra'a Mohammad Alshawamreh; Yassen Alfoteih; Andrea K Mogas; Rabih Halwani; Qutayba Hamid
Journal:  Ann Thorac Med       Date:  2022-07-09       Impact factor: 2.535

7.  Systemic corticosteroids could be used as bridge treatment in children with obstructive sleep apnea syndrome waiting for surgery.

Authors:  M Evangelisti; M Barreto; G Di Nardo; M Del Pozzo; P Parisi; Maria Pia Villa
Journal:  Sleep Breath       Date:  2021-07-24       Impact factor: 2.816

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.